Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study
for Neovascular Age-Related Macular Degeneration (nAMD)
Sites in Santa Barbara, Bakersfield +6 more locations
Sponsor: Ocular Therapeutix, Inc.
Sex: All·Age: 50+
Code: NCT07516132·Phase 3·Recruiting·Listed Apr 2026